missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Mouse SIGNR1/CD209b Antibody, R&D Systems™

Goat Polyclonal Antibody has been used in 3 publications
£168.00 - £432.00
Specifications
| Antigen | SIGNR1/CD209b |
|---|---|
| Concentration | LYOPH |
| Dilution | Western Blot 0.1 ug/mL, Adhesion Blockade 10 ug/mL |
| Applications | Western Blot, Adhesion Blockade |
| Classification | Polyclonal |
| Product Code | Brand | Quantity | Price | Quantity & Availability | |||||
|---|---|---|---|---|---|---|---|---|---|
| Product Code | Brand | Quantity | Price | Quantity & Availability | |||||
18765887
![]() |
R&D Systems
AF1836-SP |
25 μg |
£168.00
25µg |
Please sign in to purchase this item. Need a web account? Register with us today! | |||||
18039281
![]() |
R&D Systems
AF1836 |
100 μg |
£432.00
100µg |
Please sign in to purchase this item. Need a web account? Register with us today! | |||||
Description
SIGNR1/CD209b Polyclonal specifically detects SIGNR1/CD209b in Mouse samples. It is validated for Western Blot, Adhesion Blockade.Specifications
| SIGNR1/CD209b | |
| Western Blot 0.1 ug/mL, Adhesion Blockade 10 ug/mL | |
| Polyclonal | |
| Goat | |
| Mouse | |
| CD209 antigen like protein B, CD209b, DC SIGN related protein 1, DC SIGNR1, OtB7 | |
| Cd209b | |
| IgG | |
| Affinity Purified | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. |
| LYOPH | |
| Western Blot, Adhesion Blockade | |
| Unconjugated | |
| RUO | |
| Q8CJ91 | |
| 170786 | |
| Mouse myeloma cell line NS0-derived recombinant mouse SIGNR1 Ser76-Gly325 Accession # Q8CJ91 | |
| Primary | |
| Reconstitute at 0.2 mg/mL in sterile PBS. | |
| Detects mouse SIGNR1 in direct ELISAs and Western blots. In direct ELISAs, approximately 20% cross-reactivity with recombinant mouse (rm) SIGNR3 and rmSIGNR4 is observed, and approximately 10% cross-reactivity with recombinant human DC-SIGNR and rmDC-SIGN is observed. |
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title